Arvind Sathyamurthy retweeted
This Independence Day 🇮🇳, I asked, "What will the next century of young Indians look like?"
$0.01 Drone Deliveries. UAVs that never land. Groceries in under 10 minutes.
Meet The 22nd Century Indian. A Documentary on a New India.
Arvind Sathyamurthy retweeted
Excited to share that our phase 2 trial #NeoLOCUS is now out in @LancetRH_SEAsia! A collective effort from the Head & Neck team @OffCMCVellore led by @todrashish
We report R0 rates, ORR, safety, survival outcomes, tumor immune microenvironment change🧵👇
thelancet.com/journals/lanse…
Arvind Sathyamurthy retweeted
We had a fantastic time celebrating our New Fellows during yesterday's Admission Ceremony!
Congratulations once again on this momentous occasion 👏
#RCRFellows
Arvind Sathyamurthy retweeted
PRAGRAD, a new patient-driven treatment approach for very advanced oral cavity #cancers (which cannot be surgically removed) shows significant improvement in patient outcomes: prospective study by CMC #research team.
Instead of a one-size-fits-all plan, #patients are given the choice of #palliative care or aggressive chemoradiation, promoting shared decision-making and #PatientAutonomy.
It was found that when decision making was shared, more patients were willing to try aggressive chemoradiation; half the number who responded to initial #chemotherapy and continued aggressive treatment, survived over 30 months - 5 times longer than those choosing palliation (6 months). Nearly half survived beyond 2 years - a remarkable outcome for this advanced stage.
Read more: doi.org/10.1016/j.ijrobp.202…
@ASTRO_org
#RedJournal #CancerCare #PatientChoice
Arvind Sathyamurthy retweeted
Quite the week for head&neck unit @royalmarsdenNHS 3 major outputs. bit.ly/3T0uS4p in @NEJM with Kevin Harrington bit.ly/45snlTq ION in @TheLancet Kate Newbold @DrChrisNutting and @IReC_RM consensus bit.ly/445yc3d in @JNCI_Now
ThankYou collaborators
Arvind Sathyamurthy retweeted
💥 First practice-changing trial in over 2 decades for patients with resectable, LA HNSCC #AACR25
🌟EFS ITT 51 PembroSoC vs 30m SoC
🎯HR 0.73 (0.58-0.92)
⏱️OS inmature
Congrats to all my colleagues at @royalmarsdenNHS H&N unit, rest of sites, sponsor💪@OncoAlert @brunolarvol
Arvind Sathyamurthy retweeted
We're hiring! Clinical Oncology Research Fellow opportunity at @royalmarsdenNHS @ICR_London to work on the landmark PACE trial & future prostate radiotherapy studies. Work with me, @EmmaHall71 @y_suhughes Join us! #OncologyJobs royalmarsden.nhs.uk/current-…
@alison_tree @cpeedell
Arvind Sathyamurthy retweeted
congratulations 🎊
Very important findings, as we try to bring these expensive lifesaving treatment to people who can not afford to pay for the same.. @brunolarvol @FordePatrick @JCO_ASCO @OncoAlert @DrSanjayPopat
“When Less Is Truly More”
Excited to share our work from Med Onc @OffCMCVellore published in @JCOGO_ASCO
"Does adding low dose Nivo to NACT ⬆️response rates & survival in stage III non-oncogene-driven NSCLC?"
🔗doi.org/10.1200/GO-24-00256
Mentor @todrashish
Key findings👇🧵#LCSM
Arvind Sathyamurthy retweeted
🧬🚨 New Study Alert! 🚨🧬 Our recent work dived into into BRCA1/2 mutations in India. There is limited data on population specific BRCA mutations in 🇮🇳. We used NGS to analyze 921 Indian women with suspected hereditary breast and ovarian cancer (HBOC). @OffCMCVellore
#BRCA
Arvind Sathyamurthy retweeted
39th Annual #Conference of the Association of #RadiationOncologists of India (AROI), #TamilNadu
& #Puducherry Chapter, organised by Dept of #Radiation #Oncology, Ida B Scudder #Cancer Centre, on 20th and 21st. Conference also marked 85th anniversary of the dept at #CMCVellore.
Arvind Sathyamurthy retweeted
#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients @DrTolan @alison_tree @cpeedell @DrAndrewLoblaw @EmmaHall71 @ProfJOSullivan authors.elsevier.com/sd/arti… – at Kensington, London
Arvind Sathyamurthy retweeted
Arvind Sathyamurthy retweeted
🚨New Book on Low-Dose Radiation for Painful Musculoskeletal Conditions🚨 Free Download Now Available
Over the past year, there has been a remarkable surge of interest in using low-dose radiotherapy to treat painful musculoskeletal conditions like osteoarthritis, plantar fasciitis, tendonitis, and bursitis. Many have inquired about how to initiate a program, secure institutional backing, leverage social media for promotion, and explore the supporting literature for these treatments.
This interest inspired Dr. Richard Shaffer and me to author a book designed to assist radiation oncologists and administrators in launching such programs. The book will serve as an excellent supplement to a structured training program.
❇️ The book is now available. Click on the link below to download 👇
❇️ All I request is for you to hit the repost button below so this can reach as many radiation oncologists as possible 👇
#radonc
motivated-designer-9812.ck.p…
Arvind Sathyamurthy retweeted
1/ 📢 Excited to share our study led by @heberrewbright @todrashish & Sujith J Chandy(@ICARS_global) published in @JCOGO_ASCO investigating the role of capsaicin in⬇️CINV: an investigator-initiated RCT @ajoel_84 @ajoyojohn @divyathumaty @OffCMCVellore ascopubs.org/doi/full/10.120…
Arvind Sathyamurthy retweeted
Can MRI and CT Radiomics Predict Treatment Outcome in Rectal Cancer? Pre-treatment MRI with clinical features shows potential. Personalization strategies (e.g. aggressive Tx for high-risk, organ preservation for low-risk patients need accurate predictors. rdcu.be/dKrFt
Arvind Sathyamurthy retweeted
In addition to being a TV and media star, it turns out @VinPaleri is really rather good at #hnscc surgery.
#SuperSurgeon Professor Vin Paleri is appearing in this series of Super Surgeons on @Channel4.
Sign up for our emails and get the latest updates: bit.ly/3xeerds
Arvind Sathyamurthy retweeted
Kevin Harrington showing exciting clinical and preclinical data on modulating immune response at #ESTRO24‼️
Super impressive clinical responses to ATR inhibition + low dose #radiotherapy in HNSCC🔥 (cant post)
@lauremarignol
Arvind Sathyamurthy retweeted
Dept of #Neonatology recently organised an 'NICU Graduates' Reunion' for premature babies who were under their care. More than 40 children with a birth weight of less than a kilo - currently between 2 and 5 years of age - participated along with their families.
Arvind Sathyamurthy retweeted
Our story of how the National Cancer Grid @CancerGridIndia drastically reduced costs of cancer care in India. A model that can (and should) be replicated in other disease areas and geographies. Economies of scale, assured quality, reduced stockouts (1/2)
bbc.com/news/business-676787…
Arvind Sathyamurthy retweeted
Radiotherapy sentiment in @NYTimes is eye-opening. Since 2009, over half of articles show negative bias towards RT, while only 1/4 are positive. Despite major advancements in tech like MR-Linac, adaptive RT, & heavy ions, media celebration is scarce.
thegreenjournal.com/article/…
1/7













































